Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
|
|
|
19.
|
TET2 binds the androgen receptor and loss is associated with prostate cancer. [electronic resource] by
- Nickerson, M L
- Das, S
- Im, K M
- Turan, S
- Berndt, S I
- Li, H
- Lou, H
- Brodie, S A
- Billaud, J N
- Zhang, T
- Bouk, A J
- Butcher, D
- Wang, Z
- Sun, L
- Misner, K
- Tan, W
- Esnakula, A
- Esposito, D
- Huang, W Y
- Hoover, R N
- Tucker, M A
- Keller, J R
- Boland, J
- Brown, K
- Anderson, S K
- Moore, L E
- Isaacs, W B
- Chanock, S J
- Yeager, M
- Dean, M
- Andresson, T
Producer: 20170419
In:
Oncogene vol. 36
Availability: No items available.
|